Chugai Pharmaceutical Co., Ltd. (TYO:4519)
Japan · Delayed Price · Currency is JPY 6,787.00
-148.00 (-2.13%)
Oct 27, 2025, 3:30 PM JST
Chugai Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 397,161 | 387,317 | 325,472 | 374,429 | 302,995 | 214,733 | Upgrade |
Depreciation & Amortization | 32,765 | 31,665 | 31,740 | 31,434 | 30,868 | 30,376 | Upgrade |
Loss (Gain) From Sale of Assets | -1,421 | 4,377 | -21,881 | 641 | 6,342 | 953 | Upgrade |
Asset Writedown & Restructuring Costs | 5,798 | - | - | - | - | - | Upgrade |
Stock-Based Compensation | 383 | - | - | - | - | - | Upgrade |
Other Operating Activities | -16,785 | -101,510 | -180,718 | -152,074 | -104,102 | -65,247 | Upgrade |
Change in Other Net Operating Assets | -8,334 | 125,751 | 255,312 | -10,318 | 43,523 | 24,220 | Upgrade |
Operating Cash Flow | 409,567 | 447,600 | 409,925 | 244,112 | 279,626 | 205,035 | Upgrade |
Operating Cash Flow Growth | -2.35% | 9.19% | 67.92% | -12.70% | 36.38% | -0.78% | Upgrade |
Capital Expenditures | -59,218 | -50,415 | -71,948 | -62,625 | -65,969 | -57,040 | Upgrade |
Sale of Property, Plant & Equipment | 7,285 | -510 | 19,346 | 1,048 | 1,042 | -22 | Upgrade |
Sale (Purchase) of Intangibles | -17,829 | -1,685 | 12,850 | -8,614 | -6,897 | -4,349 | Upgrade |
Investment in Securities | 10,193 | -177,539 | 979 | -76,083 | -47,236 | -37,001 | Upgrade |
Other Investing Activities | 3,117 | 2,784 | 1,483 | 280 | 133 | 100 | Upgrade |
Investing Cash Flow | -56,452 | -227,365 | -37,290 | -145,994 | -118,927 | -98,312 | Upgrade |
Issuance of Common Stock | 146 | 168 | 217 | 241 | 322 | 440 | Upgrade |
Repurchase of Common Stock | -4 | -10 | -5 | -5 | -8 | -30 | Upgrade |
Common Dividends Paid | -299,832 | - | - | - | - | - | Upgrade |
Dividends Paid | -299,832 | -133,249 | -131,594 | -138,220 | -98,644 | -91,442 | Upgrade |
Other Financing Activities | 18 | -7,915 | -7,949 | -7,657 | -9,078 | -8,465 | Upgrade |
Financing Cash Flow | -307,663 | -141,006 | -139,331 | -145,641 | -107,408 | -99,497 | Upgrade |
Foreign Exchange Rate Adjustments | 7,023 | 2,299 | 3,202 | 1,939 | 2,128 | 1,166 | Upgrade |
Miscellaneous Cash Flow Adjustments | -1 | - | -1 | - | - | 1 | Upgrade |
Net Cash Flow | 52,474 | 81,528 | 236,505 | -45,584 | 55,419 | 8,393 | Upgrade |
Free Cash Flow | 350,349 | 397,185 | 337,977 | 181,487 | 213,657 | 147,995 | Upgrade |
Free Cash Flow Growth | -0.19% | 17.52% | 86.23% | -15.06% | 44.37% | -3.67% | Upgrade |
Free Cash Flow Margin | 28.87% | 33.93% | 30.41% | 14.40% | 21.37% | 18.81% | Upgrade |
Free Cash Flow Per Share | 212.89 | 241.36 | 205.40 | 110.30 | 129.87 | 89.96 | Upgrade |
Cash Interest Paid | 310 | 94 | 81 | 58 | 48 | 34 | Upgrade |
Cash Income Tax Paid | 190,757 | 100,477 | 176,074 | 152,082 | 104,074 | 66,785 | Upgrade |
Levered Free Cash Flow | 318,235 | 338,816 | 317,041 | 148,160 | 177,704 | 124,969 | Upgrade |
Unlevered Free Cash Flow | 318,305 | 338,813 | 317,058 | 148,198 | 177,734 | 125,008 | Upgrade |
Change in Working Capital | -8,334 | 125,751 | 255,312 | -10,318 | 43,523 | 24,220 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.